These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9423248)

  • 1. Bayesian design for dose-response curves with penalized risk.
    Sun D; Tsutakawa RK
    Biometrics; 1997 Dec; 53(4):1262-73. PubMed ID: 9423248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing experimental designs for benchmark dose calculations for continuous endpoints.
    Kuljus K; von Rosen D; Sand S; Victorin K
    Risk Anal; 2006 Aug; 26(4):1031-43. PubMed ID: 16948695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian approach to a logistic regression model with incomplete information.
    Choi T; Schervish MJ; Schmitt KA; Small MJ
    Biometrics; 2008 Jun; 64(2):424-30. PubMed ID: 17764482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian analysis of a dose-response experiment with serial sacrifices.
    Bratcher TL
    J Environ Pathol Toxicol; 1977; 1(2):287-92. PubMed ID: 553135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penalized loss functions for Bayesian model comparison.
    Plummer M
    Biostatistics; 2008 Jul; 9(3):523-39. PubMed ID: 18209015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of number of doses for maximum likelihood estimation of the ED50 for quantal dose-response data.
    Müller HG; Schmitt T
    Biometrics; 1990 Mar; 46(1):117-29. PubMed ID: 2350566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian nonparametric estimation of continuous monotone functions with applications to dose-response analysis.
    Bornkamp B; Ickstadt K
    Biometrics; 2009 Mar; 65(1):198-205. PubMed ID: 18510655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian decision procedures for dose-escalation based on evidence of undesirable events and therapeutic benefit.
    Whitehead J; Zhou Y; Stevens J; Blakey G; Price J; Leadbetter J
    Stat Med; 2006 Jan; 25(1):37-53. PubMed ID: 16342336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian fitting of a logistic dose-response curve with numerically derived priors.
    Huson LW; Kinnersley N
    Pharm Stat; 2009; 8(4):279-86. PubMed ID: 18819118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical and Bayesian inference in neuroimaging: applications.
    Friston KJ; Glaser DE; Henson RN; Kiebel S; Phillips C; Ashburner J
    Neuroimage; 2002 Jun; 16(2):484-512. PubMed ID: 12030833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model uncertainty and risk estimation for experimental studies of quantal responses.
    Bailer AJ; Noble RB; Wheeler MW
    Risk Anal; 2005 Apr; 25(2):291-9. PubMed ID: 15876205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian transformation cure frailty models with multivariate failure time data.
    Yin G
    Stat Med; 2008 Dec; 27(28):5929-40. PubMed ID: 18618427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian information criterion for longitudinal and clustered data.
    Jones RH
    Stat Med; 2011 Nov; 30(25):3050-6. PubMed ID: 21805487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
    Marino DJ; Starr TB
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):285-300. PubMed ID: 17949874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor unit number estimation--a Bayesian approach.
    Ridall PG; Pettitt AN; Henderson RD; McCombe PA
    Biometrics; 2006 Dec; 62(4):1235-50. PubMed ID: 17156299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian proportional hazards model with time-varying regression coefficients: a penalized Poisson regression approach.
    Lambert P; Eilers PH
    Stat Med; 2005 Dec; 24(24):3977-89. PubMed ID: 16320263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian perspectives for epidemiological research. II. Regression analysis.
    Greenland S
    Int J Epidemiol; 2007 Feb; 36(1):195-202. PubMed ID: 17329317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequentist performance of Bayesian confidence intervals for comparing proportions in 2 x 2 contingency tables.
    Agresti A; Min Y
    Biometrics; 2005 Jun; 61(2):515-23. PubMed ID: 16011699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian predictive two-stage design for phase II clinical trials.
    Sambucini V
    Stat Med; 2008 Apr; 27(8):1199-224. PubMed ID: 17763528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.